Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy

Authors :: Shari Goldfarb
Chau T. Dang
Maura N. Dickler
Tiffany A. Troso-Sandoval
Clifford A. Hudis
Neil M. Iyengar
Tiffany A. Traina
P. Defusco
A. Latif
Diana Lake
Monica Fornier
Jasmeet Chadha Singh
Ayca Gucalp
Komal Jhaveri
L. Smyth
J. Baselga
Shanu Modi
Larry Norton
G. Ulaner
M. Jochelson
Source :: Annals of Oncology. 27:vi84
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: 0301 basic medicine
Oncology
medicine.medical_specialty
business.industry
Phases of clinical research
Hematology
medicine.disease
Metastatic breast cancer
03 medical and health sciences
Gemcitabine/Trastuzumab
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
Pertuzumab
business
medicine.drug

Full Text Access

Tools